Compare YHGJ & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | YHGJ | DRIO |
|---|---|---|
| Founded | 1975 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.1M | 70.6M |
| IPO Year | 2006 | 2013 |
| Metric | YHGJ | DRIO |
|---|---|---|
| Price | $2.68 | $6.61 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | 1.5K | ★ 14.9K |
| Earning Date | 05-19-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.75 |
| Revenue | ★ $19,705,000.00 | $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ N/A | $3.83 |
| Revenue Growth | 9.76 | ★ 43.02 |
| 52 Week Low | $2.38 | $5.84 |
| 52 Week High | $10.29 | $17.74 |
| Indicator | YHGJ | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 44.64 | 43.14 |
| Support Level | $2.59 | $6.49 |
| Resistance Level | $3.09 | $8.10 |
| Average True Range (ATR) | 0.15 | 0.25 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 33.00 | 11.94 |
Yunhong Green CTI Ltd develops, produces, distributes, and sells consumer products in the United States and several other countries, and manufactures film products for commercial and industrial use in the United States. The Company focuses on flexible film technologies and has developed products utilizing flexible films, including novelty balloons, pouches, and films for packaging applications. Its principal product lines include foil and latex balloons and related gift items, and flexible films for food and other packaging uses. It also assembles balloon-inspired gift items, including small gift bouquets with ribbons and/or a foil balloon, and holds patents related to flexible films, including films, zipper closures, valves, and other features.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.